换一批
换一批A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Ménière's disease.
作者：
主题词
成年人(Adult);老年人(Aged);地塞米松(Dexamethasone);剂量效应关系, 药物(Dose-Response Relationship, Drug);双盲法(Double-Blind Method);用药计划表(Drug Administration Schedule);女(雌)性(Female);糖皮质激素类(Glucocorticoids);人类(Humans);男(雄)性(Male);梅尼埃病(Meniere Disease);中年人(Middle Aged);安慰剂(Placebos);治疗结果(Treatment Outcome);鼓膜(Tympanic Membrane);眩晕(Vertigo)
DOI
10.1097/MAO.0b013e318263d35d
PMID
22858715
发布时间
2022-03-16
- 浏览46
![Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology](https://img.med.wanfangdata.com.cn/imgs/qkindeximg/100961504/100961504.jpg)
Otology & neurotology
1257-65页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
